Results 261 to 270 of about 143,284 (315)

Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma. [PDF]

Curr Oncol
Bettazzi B, Salvestrini V, Banini M, Ruggieri O, Palomba A, Galli IC, Livi L, Bonomo P, Becherini C.   +8 more
europepmc   +1 more source

T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma. [PDF]

Mol Cancer Ther
Sywanycz S, Hill BL, Miller ZA, Turner G, Huang L, Polen K, Lee RJ, Carey RM.   +7 more
europepmc   +1 more source

Clinical and economic burden of recurrence among older patients with locoregionally advanced head and neck squamous cell carcinoma in the United States. [PDF]

J Manag Care Spec Pharm
Zheng D, Zhang S, Bidadi B, Lerman N, Song Y, Tang Y, Song R, Li J, Zhu A, Signorovitch J, Merchant S, Hanna GJ.   +11 more
europepmc   +1 more source

Integrin α5β1 in head and neck squamous cell carcinoma: expression, mechanisms, and clinical implications. [PDF]

Am J Cancer Res
Wu B, Ma HZ, Shang JJ, Zhao XY, Wang ZY, Qiu LL.   +5 more
europepmc   +1 more source

Mechanistic investigation of artesunate against head and neck squamous cell carcinoma through network pharmacology and experimental validation. [PDF]

Discov Oncol
Wei L, He D, Jia L, Mo H, Ma H, Wu X, Yuan W.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Squamous cell carcinoma in the head and neck

British Journal of Hospital Medicine, 2007
Head and neck cancers are responsible for 10% of male cancers in the UK, and used to be six or seven times more common in men than women. Now these cancers are only about twice as common among men. This article reviews the presentation and management of these cancers.
Hiba, Al-Reefy, Vikram, Dhar, Mike, Dilkes   +2 more
openaire   +2 more sources

Squamous cell carcinoma radioimmunoassay in squamous cell carcinoma of the head and neck

The American Journal of Surgery, 1989
Tumor-associated antigen has shown promise as a clinical aid in the detection and monitoring of uterine cervical squamous cell carcinoma. Antigen levels have been shown to reflect the extent of disease and response to treatment. These findings have suggested that measurements of tumor-associated antigen may be useful in monitoring other squamous cell ...
D W, Cook, T, Winek, H, Baker, C W, Deveney, T, Sasaki   +4 more
openaire   +2 more sources

Neck dissection for squamous cell carcinoma of the head and neck

Otolaryngology–Head and Neck Surgery, 2007
To investigate the successes and failures of 172 patients receiving neck dissections for squamous cell carcinoma (SCC) managed through a multidisciplinary head and neck clinic and to observe factors in predicting failure (death with head and neck cancer or local regional recurrence) or local regional recurrence alone.A retrospective, 14-year surgical ...
Peter L, Santa Maria, Chady, Sader, Neil J M, Preston, Philip H, Fisher   +3 more
openaire   +2 more sources